Tag: Cancer: Misc.
Health Insurance Coverage Disruption Impedes Cancer Care
Findings consistent across cancer continuum, from screening to treatment and end-of-life care
Fewer Children Enrolling in Pediatric Cancer Trials
Adolescent and young adult cancer patients underrepresented in clinical trials
Patients With Cancer Seem More Vulnerable to COVID-19
Frequency of severe events highest for patients with hematologic cancer, lung cancer, and metastatic cancer
American Association for Cancer Research, April 27-28
The American Association for Cancer Research Annual Meeting 2020 The annual meeting of the American Association for Cancer Research was held virtually this...
Impact of COVID-19 on Oncology Clinical Trials Discussed
Recommendations for sustaining cancer care access include permanent expanded support for telehealth
April 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2020. This roundup includes...
COVID-19 Case Fatality Rate Increased for Cancer Patients
Case fatality rates were 37 and 25 percent for hematologic and solid malignancies, respectively
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
Multicancer Blood Test, PET-CT Combo Feasible for Cancer Screen
One percent of participants underwent PET-CT imaging due to false-positive blood tests
Pediatric Brain Cancer Outcomes Worse for Black, Hispanic Patients
Disparities for disease severity not seen at diagnosis, meaning postdiagnosis factors may affect outcome
